六月 2026
slas-discovery.org
显示 Similarweb 估计数据。
关联 GA4,公开验证您的网站指标
与您的成功同步
绑定 Google Analytics,验证您网站的流量及用户参与度指标
跳出率
48.86%
每次访问页数
1.67
平均访问时长
00:00:53
- 公司
- - -
- 行业
- - -
slas-discovery.org的 10 大竞争对手
在 六月 2026 与 slas-discovery.org 相似的前 10 名网站,按关键字流量、受众定位和市场重叠方面与 slas-discovery.org 的关联性排名
- 公司
- - -
- 行业
- - -
跳出率
37.03%
每次访问页数
1.91
平均访问时长
00:00:41
Get up to date with the latest announcements from SLA.
跳出率
32.07%
每次访问页数
5.01
平均访问时长
00:02:07
相似度评分
82%Have you heard? SLAS Technology and SLAS Discovery are now open access journals! We are excited about this change because: All articles published open access are immediately and permanently free for everyone to read, dow
- 公司
- - -
- 行业
- - -
跳出率
39.67%
每次访问页数
1.75
平均访问时长
00:00:57
相似度评分
77%West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products.
跳出率
50.46%
每次访问页数
2.63
平均访问时长
00:00:53
Find all Evotec investor relations information and news articles.
跳出率
43.59%
每次访问页数
2.05
平均访问时长
00:01:04
相似度评分
68%Contact To learn more about Noema Pharma’s pipeline, our investment outlook, and potential, or to submit a general inquiry, please use the form below. All f ...
- 公司
- - -
- 行业
- - -
跳出率
76.35%
每次访问页数
1.23
平均访问时长
00:00:06
Laurent Lévy is the Cofounder of Nanobiotix and has served as Chief Executive Officer since 2003. He was first appointed as Chairman of the Executive Board on May 27, 2004. Laurent has extensive experience in the sciences and techniques related to nanotechnology. Prior to founding Nanobiotix, Laurent served as a consultant for Altran Technologies and worked in the development of nanotechnologies with companies such as Sanofi S.A., Guerbet S.A., Rhodia S.A., and other early-stage biotechnology companies. He served as President of the Supervisory Board of Valbiotis S.A. (Euronext Paris: ALVAL), was Vice Chairman of the Executive Board of the European Technology Platform on Nanomedicine (ETPN), and was a founding member of the Nanomedicine Translation Advisory Board (a division of ETPN). Laurent has authored more than 35 scientific publications, has applied for and secured several patents, and regularly speaks on the topic of using nanoparticles to fight cancer and other diseases. He holds a doctorate in physical chemistry, specializing in nanomaterials, from the Pierre and Marie Curie University (Université Paris VI Pierre et Marie Curie; UPVI-ESPCI) in Paris and from the Commissariat à l’Énergie Atomique et aux Énergies Alternatives (CEA), and a DEA (advanced studies and diplomas) in physics of condensed matter from the UPVI-ESPCI. Laurent completed his studies with a postdoctoral fellowship at the Institute for Lasers, Photonics and Biophotonics at the State University of New York at Buffalo (SUNY Buffalo).
跳出率
45.44%
每次访问页数
1.72
平均访问时长
00:00:15
Learn more about Arvinas' website terms of use.
跳出率
49.2%
每次访问页数
1.80
平均访问时长
00:00:43
相似度评分
61%slas-discovery.org在 六月 2026 的前五名竞争对手是:slas-technology.org、sla.gov.sg、aegweb.org、slas.org等。
根据 Similarweb 的月访问量数据,slas-discovery.org 在 六月 2026 的头号竞争对手是 slas-technology.org。与 slas-discovery.org 相似度排名第二的网站是 sla.gov.sg,排名第三的是 aegweb.org。
在 六月 2026,slas.org 被评为与 slas-discovery.org 相似度第四高的网站,westpharma.com 位居第五。
进入前十名榜单的其他五家竞争对手分别是 evotec.com、noemapharma.com、spyre.com、nanobiotix.com 和 arvinas.com。
